173 related articles for article (PubMed ID: 35665853)
1. Use of selective laser trabeculoplasty as an alternative in patients who developed ocular hypertension after intravitreal dexamethasone implants: a series of 35 eyes.
Billant J; Agard E; Douma I; Levron A; Brunet O; Remignon CH; Sejournet L; Dot C
Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3665-3673. PubMed ID: 35665853
[TBL] [Abstract][Full Text] [Related]
2. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
[TBL] [Abstract][Full Text] [Related]
3. Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial.
Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G;
Ophthalmology; 2019 Sep; 126(9):1238-1248. PubMed ID: 31028768
[TBL] [Abstract][Full Text] [Related]
4. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
[TBL] [Abstract][Full Text] [Related]
5. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
6. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Adeleke M; Vickerstaff V; Ambler G; Hunter R; Bunce C; Nathwani N; Barton K;
Ophthalmology; 2023 Feb; 130(2):139-151. PubMed ID: 36122660
[TBL] [Abstract][Full Text] [Related]
7. An Exploratory Retrospective Data Analysis Comparing the Outcomes of Selective Laser Trabeculoplasty and Argon Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension in Vienna, Austria, from the Year 2012 to 2022.
Schmidl D; Hommer N; Hommer A
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138178
[No Abstract] [Full Text] [Related]
8. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
Nagar M; Ogunyomade A; O'Brart DP; Howes F; Marshall J
Br J Ophthalmol; 2005 Nov; 89(11):1413-7. PubMed ID: 16234442
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of pattern scanning laser trabeculoplasty and selective laser trabeculoplasty: Results from the lausanne laser trabeculoplasty registry.
Elahi S; Rao HL; Paillard A; Mansouri K
Acta Ophthalmol; 2021 Mar; 99(2):e154-e159. PubMed ID: 32602256
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of selective laser trabeculoplasty and its safety on corneal endothelium in patients with primary open angle glaucoma and ocular hypertension.
Gedik S; Gulseren O
Niger J Clin Pract; 2022 Dec; 25(12):2046-2052. PubMed ID: 36537464
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Selective Laser Trabeculoplasty on Intraocular Pressure in Patients with Dexamethasone Intravitreal Implant-Induced Elevated Intraocular Pressure.
Bennedjai A; Theillac V; Akesbi J; Adam R; Rodallec T; Keilani C; Blumen-Ohana E; Labbé A; Nordmann JP
J Ophthalmol; 2020; 2020():3439182. PubMed ID: 33110658
[TBL] [Abstract][Full Text] [Related]
12. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
Best UP; Domack H; Schmidt V
Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
[TBL] [Abstract][Full Text] [Related]
13. Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension and primary open-angle glaucoma.
Shazly TA; Latina MA; Dagianis JJ; Chitturi S
Cornea; 2012 Aug; 31(8):883-6. PubMed ID: 22525783
[TBL] [Abstract][Full Text] [Related]
14. [Selective laser trabeculoplasty: Effect of number of preoperative topical glaucoma medications on pressure lowering and success rate].
Bonnel S; Fenolland JR; Marill AF; Gaillard R; Rosenberg R; Theillac V; Mazharian A; Giraud JM; Renard JP
J Fr Ophtalmol; 2017 Jan; 40(1):22-28. PubMed ID: 28081918
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of selective laser trabeculoplasty and pattern scanning laser trabeculoplasty: a randomised clinical trial.
Wong MOM; Lai IS; Chan PP; Chan NC; Chan AY; Lai GW; Chiu VS; Leung CK
Br J Ophthalmol; 2021 Apr; 105(4):514-520. PubMed ID: 32606078
[TBL] [Abstract][Full Text] [Related]
16. Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty.
Ghosn C; Rajagopalan L; Ugarte S; Mistry S; Orilla W; Goodkin ML; Robinson MR; Engles M; Dibas M
J Ocul Pharmacol Ther; 2022 May; 38(4):311-318. PubMed ID: 35442770
[No Abstract] [Full Text] [Related]
17. Ocular hypertension and intravitreal steroids injections, update in 2023. French guidelines of the French glaucoma society and the French ophthalmology society.
Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
J Fr Ophtalmol; 2023 Oct; 46(8):e249-e256. PubMed ID: 37302867
[TBL] [Abstract][Full Text] [Related]
18. Impact of laser pulse duration on the reduction of intraocular pressure during selective laser trabeculoplasty.
Stunf Pukl S; Drnovšek-Olup B
Int Ophthalmol; 2018 Feb; 38(1):83-91. PubMed ID: 28040851
[TBL] [Abstract][Full Text] [Related]
19. [Intraocular pressure elevation and intravitreal steroid implant injection: State of the art in 2023. Recommendations of the French Glaucoma Society and French Ophthalmology Society [French version]].
Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
J Fr Ophtalmol; 2023 Sep; 46(7):803-810. PubMed ID: 37481449
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma.
AlObaida I; Al Owaifeer AM; Alotaibi H; Alsafi A; Ali Aljasim L
Eur J Ophthalmol; 2022 May; 32(3):1525-1529. PubMed ID: 34096363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
